98 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ARRY Array BioPharma Inc. $16.98 $3.53B Uptrend
Article Searches
What's Behind Array Biopharma Inc.'s 31% Rally in August? https://www.fool.com/investing/2017/09/06/why-array-biopharma-inc-stock-swelled-31-in-august.aspx?source=iedfolrf0000001 Sep 06, 2017 - The company's lead candidates took another step forward last month.
Two To Trade? MiMedX And Array https://seekingalpha.com/article/4101997-two-trade-mimedx-array?source=feed_all_articles Aug 25, 2017 - Their average share price is up an excellent 166%, whilst this figure over the year to date stands at 47.8%.Array, with a market capitalization of $1.693bn, and currently trading at $9.50.MiMedx is ba
Array BioPharma (ARRY) Looks Good: Stock Adds 5.9% in Session http://www.zacks.com/stock/news/273127/array-biopharma-arry-looks-good-stock-adds-59-in-session?cid=CS-ZC-FT-273127 Aug 24, 2017 - Array BioPharma (ARRY) shares rose nearly 6% in the last trading session, amid huge volumes.
Array BioPharma: Making The Transition To Commercial-Stage https://seekingalpha.com/article/4100576-array-biopharma-making-transition-commercial-stage?source=feed_all_articles Aug 21, 2017 - Shares are trading flat year to date and the stock remains solidly in value territory, even in the absence of near-term drivers.Clinical trial collaborations with Merck and Bristol-Myers Squibb bode w
Array BioPharma Inc (ARRY) Files –…-K for the Fiscal Year Ended on June ‘…, —…–7 http://www.gurufocus.com/news/552772/array-biopharma-inc-arry-files-10k-for-the-fiscal-year-ended-on-june-30-2017 Aug 11, 2017 - Array BioPharma Inc (ARRY) Files 10-K for the Fiscal Year Ended on June 30, 2017, Stocks: ARRY, release date:Aug 11, 2017
Array BioPharma's (ARRY) CEO Ron Squarer on Q2 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4096958-array-biopharmas-arry-ceo-ron-squarer-q2-2017-results-earnings-call-transcript?source=feed_all_articles Aug 09, 2017 - Array BioPharma Inc. (NASDAQ:ARRY) Q2 2017 Earnings Conference Call August 9, 2017 9:00 AM ET Executives Tricia Haugeto - Investor Relations Ron Squarer - Chief Executive Officer Jason Haddock - Chief
Array BioPharma Inc. 2017 Q4 - Results - Earnings Call Slides https://seekingalpha.com/article/4096790-array-biopharma-inc-2017-q4-results-earnings-call-slides?source=feed_all_articles Aug 09, 2017 - The following slide deck was published by Array BioPharma Inc. in conjunction with their 2017 Q4 earnings call.
Here's Why Array BioPharma Inc. Fell 13.7% in July https://www.fool.com/investing/2017/08/07/heres-why-array-biopharma-inc-fell-137-in-may.aspx?source=iedfolrf0000001 Aug 07, 2017 - Despite sharing upbeat news, shares of the clinical-stage biotech fell by double-digits.
New Arris boxes integrate TiVo, ease streaming offerings https://seekingalpha.com/news/3280756-new-arris-boxes-integrate-tivo-ease-streaming-offerings?source=feed_news_all Jul 24, 2017 - Set-top box stalwart Arris (ARRS +0.7%) is rolling out a new set of boxes integrating TiVo's (NASDAQ:TIVO) platform, and supporting a trade group program that allows independent cable operators to of
3 Things In Biotech You Should Learn Today: July 19, 2017 https://seekingalpha.com/article/4088267-3-things-biotech-learn-today-july-19-2017?source=feed_all_articles Jul 19, 2017 - Puma finally gets the approval it's been waiting for.Array BioPharma switches focus, shelving development of a kinesin spindle inhibitor.Asterias marches on in its spinal cord trial.

Pages: 12345678910

<<<Page 6>